Status:
COMPLETED
Tranexamic Acid in the Prevention of Postpartum Hemorrhage in Elective Caesarean Section
Lead Sponsor:
KK Women's and Children's Hospital
Conditions:
Postpartum Hemorrhage
Tranexamic Acid
Eligibility:
FEMALE
21+ years
Phase:
PHASE3
Brief Summary
In obstetrics, postpartum haemorrhage (PPH) continues to be a major contributor to maternal morbidity and mortality worldwide. Uterine atony is the most common cause of PPH, and the prophylactic use o...
Eligibility Criteria
Inclusion
- All English speaking patients
- Above 21 year old
- Undergoing elective caesarean section.
Exclusion
- Known/suspected placenta accreta antenatally
- Contraindications to syntocinon and tranexamic acid such as hypersensitivity to these medications
- Known thrombophilia or coagulopathy
- History of thromboembolic events
- Severe cardiac/renal/liver disease
- Poorly controlled hypertension /severe preeclampsia (BP \> 160/100)/eclampsia
Key Trial Info
Start Date :
June 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04427618
Start Date
June 23 2020
End Date
February 1 2022
Last Update
November 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KK Women's and Children's Hospital
Singapore, Singapore